Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that announce the appointment of Mr Alex Renny as Managing Director.
Alex started his career in the late 80's with the British Army as a Lieutenant and Platoon Commander serving in the UK, Cyprus, Denmark, Italy and Turkey.
Following 3 years' service with the Military, he joined Chemical Bank with varying roles, cumulating in his appointment as VP Senior Trader - Interbank Trading and IR Derivatives. He has a background of Derivatives and Interbank trading, with positions at Midland Global markets and Dai-Ichi Kangyo Bank.
He took time out to complete an MBA at Cranfield School of Management following which he focused on a consulting role to a wide range of companies.
Alex was a senior management member of ROK Group where he has held numerous appointments within various subsidiaries, including Director of Corporate Development, Group CFO and Head of M & A and Corporate Strategy.
He brings to Westhouse an in depth understanding of financial markets and business expertise in both mergers and acquisitions and in corporate development. Alex also holds a BSc in Biochemistry.
Following on from Mr Renny's appointment, Jack Kaye moves to take up the role of Group Chairman.
Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.
Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.